Total Funding
73
2
Total FundingVenture - Series Unknown raised
Growth Score 73 in past quarter
-5 pts
Heat Score 2 in past quarter
-8 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
627485
Advenchen is a pharmaceutical company focusing on pharmaceutical research and development of small molecule cancer drug discovery programs.
About the Company
Advenchen Laboratories is a small pharmaceutical company focusing on pharmaceutical research and development involving small molecule cancer drug discovery programs. Our scientists are looking for small molecule kinase inhibitors, especially protein tyrosine kinases (PTK) inhibitors, that target the regulation of various PTK for cancer treatment.
Our proprietary drug development product pipeline has demonstrated strong anti-tumor activities and therapeutic benefits in various target scopes. It is believed that our novel small molecules will bring breakthrough and promising therapies as well as a prosperous future for cancer patients.
